Marshall Urist sold $502K of Royalty Pharma plc (RPRX) stock

Marshall Urist, EVP, Research & Investments of Royalty Pharma plc (RPRX), sold 9,098 shares of RPRX stock worth $502K, per an SEC Form 4 filed Jun 25, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 24, 2026, 1 day before it was made public.

RPRX has moved +7.8% since the trade date, from $54.28 to $58.52 (Sep 22, 2026 close).